PREDUCTAL

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, Romania

Active ingredients

The drug PREDUCTAL contains one active pharmaceutical ingredient (API):

1 Trimetazidine UNII 48V6723Z1P - TRIMETAZIDINE DIHYDROCHLORIDE

In patients with ischaemic heart disease, trimetazidine acts as a metabolic agent, preserving the myocardial high-energy phosphate intracellular levels. Read about Trimetazidine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01EB15	Trimetazidine	C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1109641, 1580914, 1728592
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-130016915
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004106, 1067333, 1072999
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100205443, 100327465, 100339103, 100349722, 100349870, 100363538, 100417116, 100423520, 100437024
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W07058001, W07058002, W07058003, W54945001, W54945002, W54945003